(Reuters) – Eli Lilly and Co and Incyte Corp said their rheumatoid arthritis drug baricitinib did not meet the main goal of preventing progression to
Read more
Home ยป
(Reuters) – Eli Lilly and Co and Incyte Corp said their rheumatoid arthritis drug baricitinib did not meet the main goal of preventing progression to
Read moreCOVID-19: Respiratory illness, and Obesity as a risk factor The data of the largest German cohort with a total of 50 Covid-19-Concerned, from the district
Read more